• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

接受帕金森病治疗的患者的症状。

The symptoms of patients treated for Parkinson's disease.

作者信息

Bulpitt C J, Shaw K, Clifton P, Stern G, Davies J B, Reid J L

出版信息

Clin Neuropharmacol. 1985;8(2):175-83. doi: 10.1097/00002826-198506000-00007.

DOI:10.1097/00002826-198506000-00007
PMID:4005865
Abstract

One hundred and eighty-one patients with treated Parkinson's disease completed a self-administered questionnaire on symptoms, and their responses were compared with those of 263 control subjects randomly selected from a general practice population. Nine symptoms were reported by the patients with more than a fivefold excess when compared with the controls. These included jerking of the limbs, shaking of the hands, excessive salivation, poor mental concentration, grimacing, being frozen or rooted to the spot, and hallucinations. Compared with the general control population, the patients did not have an excess of stomach or limb pain, indigestion, headache, or any decrease of interest in sex. This observational survey, unlike a randomised controlled trial, could not ensure that the different treatment groups were comparable in important respects. However, certain associations were apparent; for example, patients receiving both a decarboxylase inhibitor and levodopa tended to report fewer attacks of being frozen to the spot, fewer problems with salivation, and a reduced frequency of defaecation. Patients receiving anticholinergic drugs reported an excess of dry mouth, faintness, and dyskinesia, and fewer hot flushes.

摘要

181名接受过治疗的帕金森病患者完成了一份关于症状的自填式问卷,并将他们的回答与从普通诊所人群中随机选取的263名对照受试者的回答进行了比较。与对照组相比,患者报告的9种症状出现频率高出五倍以上。这些症状包括肢体抽搐、手部颤抖、流涎过多、注意力不集中、做鬼脸、身体僵住或呆立不动以及幻觉。与普通对照人群相比,患者没有出现胃部或肢体疼痛、消化不良、头痛增多的情况,也没有出现任何性欲减退的情况。与随机对照试验不同,这项观察性调查无法确保不同治疗组在重要方面具有可比性。然而,某些关联是明显的;例如,同时接受脱羧酶抑制剂和左旋多巴治疗的患者往往报告身体僵住发作的次数减少、流涎问题减少以及排便频率降低。接受抗胆碱能药物治疗的患者报告口干、头晕和运动障碍增多,潮热减少。

相似文献

1
The symptoms of patients treated for Parkinson's disease.接受帕金森病治疗的患者的症状。
Clin Neuropharmacol. 1985;8(2):175-83. doi: 10.1097/00002826-198506000-00007.
2
Outpatient treatment of Parkinson's disease.帕金森病的门诊治疗。
Eur Neurol. 1988;28(3):152-5. doi: 10.1159/000116254.
3
A five-year study of the incidence of dyskinesia in patients with early Parkinson's disease who were treated with ropinirole or levodopa.一项针对早期帕金森病患者使用罗匹尼罗或左旋多巴治疗后运动障碍发生率的为期五年的研究。
N Engl J Med. 2000 May 18;342(20):1484-91. doi: 10.1056/NEJM200005183422004.
4
The long-acting dopamine receptor agonist cabergoline in early Parkinson's disease: final results of a 5-year, double-blind, levodopa-controlled study.长效多巴胺受体激动剂卡麦角林用于早期帕金森病:一项为期5年的双盲、左旋多巴对照研究的最终结果
CNS Drugs. 2004;18(11):733-46. doi: 10.2165/00023210-200418110-00003.
5
The management of Parkinson's disease.帕金森病的管理
Aust N Z J Med. 1982 Apr;12(2):195-205. doi: 10.1111/j.1445-5994.1982.tb02460.x.
6
Severity of Parkinson's disease is a risk factor for peak-dose dyskinesia.帕金森病的严重程度是峰值剂量运动障碍的一个风险因素。
J Neurol Neurosurg Psychiatry. 1990 Mar;53(3):224-6. doi: 10.1136/jnnp.53.3.224.
7
Amantadine extended release for levodopa-induced dyskinesia in Parkinson's disease (EASED Study).金刚烷胺缓释剂治疗帕金森病左旋多巴诱导的异动症(EASED研究)。
Mov Disord. 2015 May;30(6):788-95. doi: 10.1002/mds.26159. Epub 2015 Feb 4.
8
Levodopa-induced dyskinesia: clinical observations.左旋多巴诱发的运动障碍:临床观察
J Neurol. 1985;232(1):29-31. doi: 10.1007/BF00314037.
9
The drug treatment of Parkinson's disease.帕金森病的药物治疗
Aust Fam Physician. 1984 May;13(5 Suppl):6-8, 11.
10
[Anticholinergics and levodopa in Parkinson's disease: an unnecessary combination in patients treated for the 1st time].[抗胆碱能药物与左旋多巴治疗帕金森病:初治患者中不必要的联合用药]
Rev Clin Esp. 1980 Dec 31;159(6):403-7.

引用本文的文献

1
Daily Habits in Parkinson's Disease: Validation of the Daily Habit Scale.帕金森病的日常习惯:日常习惯量表的验证
Mov Disord Clin Pract. 2023 Sep 8;10(10):1485-1495. doi: 10.1002/mdc3.13863. eCollection 2023 Oct.
2
Self-Reported Visual Complaints in People with Parkinson's Disease: A Systematic Review.帕金森病患者的自述视觉主诉:系统评价。
J Parkinsons Dis. 2022;12(3):785-806. doi: 10.3233/JPD-202324.
3
Measurement of the quality of life in congestive heart failure-Influence of drug therapy.充血性心力衰竭患者生活质量的测量——药物治疗的影响
Cardiovasc Drugs Ther. 1988 Nov;2(Suppl 1):419-424. doi: 10.1007/BF00633423.
4
Parkinson's disease and mitochondrial complex I: a perspective on the Ndi1 therapy.帕金森病与线粒体复合体 I:Ndi1 疗法的展望。
J Bioenerg Biomembr. 2009 Dec;41(6):493-7. doi: 10.1007/s10863-009-9249-z.
5
Nociceptive behavioral responses to chemical, thermal and mechanical stimulation after unilateral, intrastriatal administration of 6-hydroxydopamine.单侧纹状体内注射6-羟基多巴胺后对化学、热和机械刺激的伤害性行为反应
Brain Res. 2008 Jun 5;1213:41-7. doi: 10.1016/j.brainres.2008.03.053. Epub 2008 Apr 8.
6
Health-related quality-of-life measurement in patients with Parkinson's disease.帕金森病患者健康相关生活质量的测量
Pharmacoeconomics. 1999 Feb;15(2):157-65. doi: 10.2165/00019053-199915020-00004.
7
The development and validation of a short measure of functioning and well being for individuals with Parkinson's disease.帕金森病患者功能与幸福感简短测量方法的开发与验证
Qual Life Res. 1995 Jun;4(3):241-8. doi: 10.1007/BF02260863.
8
Parkinson's disease: disability, review, and management.帕金森病:残疾、综述与管理
Br Med J (Clin Res Ed). 1986 Sep 13;293(6548):675-7. doi: 10.1136/bmj.293.6548.675.